Live Breaking News & Updates on Tumor treating fields

Stay informed with the latest breaking news from Tumor treating fields on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Tumor treating fields and stay connected to the pulse of your community

Carthera partners with Agenus and Northwestern University for phase 2a trial combining SonoCloud-9 with checkpoint inhibitors to treat glioblastoma

Carthera partners with Agenus and Northwestern University for phase 2a trial combining SonoCloud-9 with checkpoint inhibitors to treat glioblastoma
menafn.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from menafn.com Daily Mail and Mail on Sunday newspapers.

France , Paris , France-general- , Northwestern-university , Illinois , United-states , Chicago , Carthera-sonocloud , Michael-canney , Adam-sonabend , Roger-stupp , Frederic-sottilini

Novocure Announces 20 Presentations On Tumor Treating Fields, Highlighting Preclinical Effects in Pancreatic Cancer and Immune Effects, at American Association for Cancer Research (AACR) Annual Meeting 2024

Novocure today announced 20 presentations on Tumor Treating Fields therapy will be delivered at the American Association for Cancer Research Annual Meeting 2024, to be held April 5 to 10 in San...

Israel , Tokyo , Japan , United-states , New-hampshire , Switzerland , San-diego , California , American , Moshe-giladi , American-association-for-cancer-research , Twitter

Novocure to Report First Quarter 2024 Financial Results

ROOT, Switzerland, April 01, 2024--Novocure (NASDAQ: NVCR) announced today that it will report financial results for the first quarter 2024 on Thursday, May 2, 2024, before the U.S. financial markets open. Novocure management will host a conference call and webcast to discuss the company’s financial results for the three months ended March 31, 2024, at 8:00 a.m. EDT on Thursday, May 2, 2024. To access the conference call by phone, use the following conference call registration link and dial-in d

Tokyo , Japan , New-hampshire , United-states , Switzerland , Israel , Exchange-commission , Twitter , Investor-relations , Tumor-treating , Tumor-treating-fields

Why NovoCure Stock Soared 18.3% This Week

Novocure announced encouraging results in a phase 3 trial for its TTFields therapy.

Miami , Florida , United-states , Novocure-ttfields , Minesh-mehta , Miami-cancer-institute , Tumor-treating-fields , Miami-cancer , Motley-fool-stock-advisor , Stock-advisor , Brain-metastases

Why Novocure Stock Is Jumping Today | The Motley Fool

Novocure had good news mixed with some not-so-good news.

Miami , Florida , United-states , Minesh-mehta , Miami-cancer-institute , Tumor-treating-fields ,

Why Novocure Stock Is Jumping Today

Novocure had good news mixed with some not-so-good news.

Miami , Florida , United-states , Minesh-mehta , Miami-cancer-institute , Tumor-treating-fields , Motley-fool-stock-advisor , Stock-advisor , Brain-metastases , Ovocure , Otley-fool-stock-advisor

Novocure (NVCR) Reports Phase 3 METIS Trial Met Primary Endpoint

Novocure (NVCR) Reports Phase 3 METIS Trial Met Primary Endpoint
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Florida , United-states , Miami , Asaf-danziger , Minesh-mehta , Baptist-health-south-florida , Miami-cancer-institute , Tumor-treating-fields , Radiation-oncology , Deputy-director , Baptist-health-south , Chief-executive

Novocure: METIS Phase 3 Clinical Trial Met Primary Endpoint, Demonstrating a Statistically Significant Extension in Time to Intracranial Progression for Patients with Brain Metastases from Non-Small Cell Lung Cancer

Novocure: METIS Phase 3 Clinical Trial Met Primary Endpoint, Demonstrating a Statistically Significant Extension in Time to Intracranial Progression for Patients with Brain Metastases from Non-Small Cell Lung Cancer
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

Miami , Florida , United-states , Israel , Switzerland , New-hampshire , Tokyo , Japan , Minesh-mehta , Dennis-riedl , Ingrid-goldberg , Asaf-danziger

Novocure's Lung Cancer Device Slows Progression to Brain in Trial, Shares Rise

Novocure said on Wednesday that its device met the main goal of a late-stage trial by slowing the progression of cancer to the brain in patients with a type of lung cancer,...

Bengaluru , Karnataka , India , Shounak-dasgupta , Shailesh-kuber , Puyaan-singh , Reuters , Tumor-treating-fields , Treating-fields , Lung-cancer , Ung-carcinoma , Ancer-of-the-lung

Novocure's lung cancer device slows progression to brain in trial, shares rise

(Reuters) -Novocure said on Wednesday that its device met the main goal of a late-stage trial by slowing the progression of cancer to the brain in patients ...

Bengaluru , Karnataka , India , Shailesh-kuber , Puyaan-singh , Shounak-dasgupta , Reuters , Tumor-treating-fields , Treating-fields ,